People · Operator

Harvey Schiller

Named in public records as an officer, director or promoter · active 2019–2019 · Other Technology, Biotechnology

2
Companies
2
Filings
$9.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
SportsGrid, Inc.Other TechnologySeries A$6.2M$172.6M2019
Iverson Genetic Diagnostics IncBiotechnologySeed$3.7M$6.3M
Operator network

Harvey Schiller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Marc Lippman · 5 companies · 1 sharedMarc LippmanJeremy Stein · 1 companies · 1 sharedJeremy SteinLouis Maione · 1 companies · 1 sharedLouis MaioneLeroy Hood · 5 companies · 1 sharedLeroy HoodDavid C Michaels · 2 companies · 1 sharedDavid C MichaelsFrank R. Ecock · 2 companies · 1 sharedFrank R. EcockBob Quillinan · 1 companies · 1 sharedBob QuillinanChristopher Dubay · 1 companies · 1 sharedChristopher DubayDean Sproles · 1 companies · 1 sharedDean SprolesDoranne Satterlee · 1 companies · 1 sharedDoranne SatterleeFrank Ecock · 1 companies · 1 sharedFrank EcockThomas J Siggia · 1 companies · 1 sharedThomas J SiggiaTom Siggia · 1 companies · 1 sharedTom SiggiaSportsGrid, Inc. · $6.2M raisedSportsGrid, Inc.Iverson Genetic Diagnostics Inc · $3.7M raisedIverson Genetic Diagn…Harvey SchillerHS
Harvey Schiller Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Harvey Schiller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Leroy Hood15
Marc Lippman15
David C Michaels12
Frank R. Ecock12
Dean Sproles11
Thomas J Siggia11
Frank Ecock11
Doranne Satterlee11
Jeremy Stein11
Louis Maione11
Bob Quillinan11
Christopher Dubay11
Tom Siggia11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.